CPBIO Holding Company Limited (HKG:3839)

CPBIO Holding Company Revenue

CPBIO Holding Company had revenue of $112.42M USD in the quarter ending June 30, 2026, a decrease of -28.98%. This brings the company's total for the last twelve months to $423.98M, down -18.95% year-over-year. In the year 2025, CPBIO Holding Company had annual revenue of $535.91M with 74.14% growth. That makes CPBIO Holding Company the 12,222nd largest company in the world by revenue and 724th in Hong Kong.

• Revenue (ttm): $423.98M
• Revenue Growth: -18.95%
• P/S Ratio: 0.59
• Revenue / Employee: $423.98K
• Employees: 1,000
• Market Cap: 1.98B HKD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• Mainland China 421.31M 78.6%
• Asia Pacific (Excluding Mainland China) 47.33M 8.8%
• Americas 44.16M 8.2%
• Europe and Elsewhere 23.11M 4.3%

Fiscal year ended Dec 31, 2025 See the full CPBIO Holding Company breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	535.91M	228.17M	74.14%
Dec 31, 2024	307.75M	133.77M	76.89%
Dec 31, 2023	173.98M	14.74M	9.26%
Dec 31, 2022	159.24M	16.83M	11.82%
Dec 31, 2021	142.41M	48.83M	52.18%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error